vs
Side-by-side financial comparison of Digital Realty (DLR) and BeOne Medicines Ltd. (ONC). Click either name above to swap in a different company.
Digital Realty is the larger business by last-quarter revenue ($1.6B vs $1.5B, roughly 1.1× BeOne Medicines Ltd.). Digital Realty runs the higher net margin — 6.0% vs 4.4%, a 1.6% gap on every dollar of revenue. On growth, BeOne Medicines Ltd. posted the faster year-over-year revenue change (32.8% vs 16.1%). Over the past eight quarters, BeOne Medicines Ltd.'s revenue compounded faster (41.2% CAGR vs 9.8%).
Digital Realty is a real estate investment trust that owns, operates and invests in carrier-neutral data centers across the world. The company offers data center, colocation, and interconnection services.
BeOne Medicines Ltd.ONCEarnings & Financial Report
BeOne Medicines, formerly known as BeiGene, Ltd. is a multinational oncology company. It specializes in the development of drugs for cancer treatment.
DLR vs ONC — Head-to-Head
Income Statement — Q1 FY2026 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $1.6B | $1.5B |
| Net Profit | $98.6M | $66.5M |
| Gross Margin | — | 90.5% |
| Operating Margin | 6.9% | 12.4% |
| Net Margin | 6.0% | 4.4% |
| Revenue YoY | 16.1% | 32.8% |
| Net Profit YoY | -10.3% | 143.8% |
| EPS (diluted) | $0.22 | $0.05 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q1 26 | $1.6B | — | ||
| Q4 25 | $1.6B | $1.5B | ||
| Q3 25 | $1.6B | $1.4B | ||
| Q2 25 | $1.5B | $1.3B | ||
| Q1 25 | $1.4B | $1.1B | ||
| Q4 24 | $1.4B | $1.1B | ||
| Q3 24 | $1.4B | $1.0B | ||
| Q2 24 | $1.4B | $929.2M |
| Q1 26 | $98.6M | — | ||
| Q4 25 | $98.6M | $66.5M | ||
| Q3 25 | $67.8M | $124.8M | ||
| Q2 25 | $1.0B | $94.3M | ||
| Q1 25 | $110.0M | $1.3M | ||
| Q4 24 | $189.6M | $-151.9M | ||
| Q3 24 | $51.2M | $-121.3M | ||
| Q2 24 | $80.2M | $-120.4M |
| Q1 26 | — | — | ||
| Q4 25 | — | 90.5% | ||
| Q3 25 | — | 86.1% | ||
| Q2 25 | — | 87.5% | ||
| Q1 25 | — | 85.2% | ||
| Q4 24 | — | 85.8% | ||
| Q3 24 | — | 83.0% | ||
| Q2 24 | — | 85.1% |
| Q1 26 | 6.9% | — | ||
| Q4 25 | 6.9% | 12.4% | ||
| Q3 25 | 8.8% | 11.5% | ||
| Q2 25 | 14.2% | 6.7% | ||
| Q1 25 | 13.9% | 1.0% | ||
| Q4 24 | 10.1% | -7.0% | ||
| Q3 24 | 11.8% | -12.0% | ||
| Q2 24 | 0.7% | -11.5% |
| Q1 26 | 6.0% | — | ||
| Q4 25 | 6.0% | 4.4% | ||
| Q3 25 | 4.3% | 8.8% | ||
| Q2 25 | 69.1% | 7.2% | ||
| Q1 25 | 7.8% | 0.1% | ||
| Q4 24 | 13.2% | -13.5% | ||
| Q3 24 | 3.6% | -12.1% | ||
| Q2 24 | 5.9% | -13.0% |
| Q1 26 | $0.22 | — | ||
| Q4 25 | $0.22 | $0.05 | ||
| Q3 25 | $0.15 | $0.08 | ||
| Q2 25 | $2.94 | $0.06 | ||
| Q1 25 | $0.27 | $0.00 | ||
| Q4 24 | $0.50 | $-0.10 | ||
| Q3 24 | $0.09 | $-0.09 | ||
| Q2 24 | $0.20 | $-0.09 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $3.5B | $4.5B |
| Total DebtLower is stronger | — | $836.4M |
| Stockholders' EquityBook value | $22.9B | $4.4B |
| Total Assets | $49.4B | $8.2B |
| Debt / EquityLower = less leverage | — | 0.19× |
8-quarter trend — quarters aligned by calendar period.
| Q1 26 | $3.5B | — | ||
| Q4 25 | $3.5B | $4.5B | ||
| Q3 25 | $3.3B | $4.0B | ||
| Q2 25 | $3.6B | $2.8B | ||
| Q1 25 | $2.3B | $2.5B | ||
| Q4 24 | $3.9B | $2.6B | ||
| Q3 24 | $2.2B | $2.7B | ||
| Q2 24 | $2.3B | $2.6B |
| Q1 26 | — | — | ||
| Q4 25 | — | $836.4M | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — |
| Q1 26 | $22.9B | — | ||
| Q4 25 | $22.9B | $4.4B | ||
| Q3 25 | $23.0B | $4.1B | ||
| Q2 25 | $22.9B | $3.8B | ||
| Q1 25 | $21.3B | $3.5B | ||
| Q4 24 | $21.3B | $3.3B | ||
| Q3 24 | $21.2B | $3.4B | ||
| Q2 24 | $20.5B | $3.4B |
| Q1 26 | $49.4B | — | ||
| Q4 25 | $49.4B | $8.2B | ||
| Q3 25 | $48.7B | $7.6B | ||
| Q2 25 | $48.7B | $6.3B | ||
| Q1 25 | $45.1B | $5.8B | ||
| Q4 24 | $45.3B | $5.9B | ||
| Q3 24 | $45.3B | $5.8B | ||
| Q2 24 | $43.6B | $5.7B |
| Q1 26 | — | — | ||
| Q4 25 | — | 0.19× | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | — | $417.3M |
| Free Cash FlowOCF − Capex | — | $379.8M |
| FCF MarginFCF / Revenue | — | 25.4% |
| Capex IntensityCapex / Revenue | — | 2.5% |
| Cash ConversionOCF / Net Profit | — | 6.28× |
| TTM Free Cash FlowTrailing 4 quarters | — | $941.7M |
8-quarter trend — quarters aligned by calendar period.
| Q1 26 | — | — | ||
| Q4 25 | $719.0M | $417.3M | ||
| Q3 25 | $652.9M | $402.6M | ||
| Q2 25 | $641.2M | $263.6M | ||
| Q1 25 | $399.1M | $44.1M | ||
| Q4 24 | $769.5M | $75.2M | ||
| Q3 24 | $566.5M | $188.4M | ||
| Q2 24 | $573.2M | $-95.6M |
| Q1 26 | — | — | ||
| Q4 25 | — | $379.8M | ||
| Q3 25 | — | $354.5M | ||
| Q2 25 | — | $219.8M | ||
| Q1 25 | — | $-12.3M | ||
| Q4 24 | — | $-17.3M | ||
| Q3 24 | — | $54.7M | ||
| Q2 24 | — | $-205.5M |
| Q1 26 | — | — | ||
| Q4 25 | — | 25.4% | ||
| Q3 25 | — | 25.1% | ||
| Q2 25 | — | 16.7% | ||
| Q1 25 | — | -1.1% | ||
| Q4 24 | — | -1.5% | ||
| Q3 24 | — | 5.5% | ||
| Q2 24 | — | -22.1% |
| Q1 26 | — | — | ||
| Q4 25 | — | 2.5% | ||
| Q3 25 | — | 3.4% | ||
| Q2 25 | — | 3.3% | ||
| Q1 25 | — | 5.0% | ||
| Q4 24 | — | 8.2% | ||
| Q3 24 | — | 13.3% | ||
| Q2 24 | — | 11.8% |
| Q1 26 | — | — | ||
| Q4 25 | 7.29× | 6.28× | ||
| Q3 25 | 9.63× | 3.22× | ||
| Q2 25 | 0.62× | 2.79× | ||
| Q1 25 | 3.63× | 34.71× | ||
| Q4 24 | 4.06× | — | ||
| Q3 24 | 11.07× | — | ||
| Q2 24 | 7.15× | — |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
